TITLE

Can Dynamic Susceptibility Contrast Magnetic Resonance Imaging Replace Single‐Photon Emission Computed Tomography in the Diagnosis of Patients with Alzheimer's Disease? A Pilot Study

AUTHOR(S)
Cavallin, L.; Danielsson, R.; Öksengard, A. R.; Wahlund, L. O.; Julin, P.; Frank, A.; Engman, E. L.; Svensson, L.; Wiberg, Kristoffersen M.
PUB. DATE
November 2006
SOURCE
Acta Radiologica;Nov2006, Vol. 47 Issue 9, p977
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: To compare single‐photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI) in a cohort of patients examined for suspected dementia, including patients with no objective cognitive impairment (control group), mild cognitive impairment (MCI), and Alzheimer's disease (AD).Material and Methods: Twenty‐four patients, eight with AD, 10 with MCI, and six controls were investigated with SPECT using 99mTc‐hexamethylpropyleneamine oxime (HMPAO) and dynamic susceptibility contrast magnetic resonance imaging (DSC‐MRI) with gadobutrol. Three observers performed a visual interpretation of the SPECT and MR images using a four‐point visual scale.Results: SPECT was superior to DSC‐MRI in differentiating normal from pathological. All three observers showed statistically significant results in discriminating between the control group, AD, and MCI by SPECT, with a P value of 0.0006, 0.04, and 0.01 for each observer. The statistical results were not significant for MR (P values 0.8, 0.1, and 0.2, respectively).Conclusion: DSC‐MRI could not replace SPECT in the diagnosis of patients with Alzheimer's disease. Several patient‐ and method‐related improvements should be made before this method can be recommended for clinical practice.
ACCESSION #
23815001

 

Related Articles

  • Usefulness of Computed Tomography Linear Measurements in Diagnosing Alzheimer's Disease. Yi Zhang; Londos, E.; Minthon, L.; Wattmo, C.; Huaijun Liu; Aspelin, P.; Wahlund, L. -O. // Acta Radiologica;Feb2008, Vol. 49 Issue 1, p91 

    Background: Medial temporal lobe atrophy (MTA) is an early sign of Alzheimer's disease (AD). The current method of choice for measuring MTA is volumetric measurement based on 3D magnetic resonance imaging (MRI), but this complicated method has not been implemented clinically. Purpose: To...

  • Voxel-Based Correlation between Coregistered Single-Photon Emission Computed Tomography and Dynamic Susceptibility Contrast Magnetic Resonance Imaging in Subjects with Suspected Alzheimer Disease. Cavallin, L.; Axelsson, R.; Wahlund, L. O.; Oksengard, A. R.; Svensson, L.; Juhlin, P.; Wiberg, M. Kristoffersen; Frank, A. // Acta Radiologica;Dec2008, Vol. 49 Issue 10, p1154 

    Background: Current diagnosis of Alzheimer disease is made by clinical, neuropsychologic, and neuroimaging assessments. Neuroimaging techniques such as magnetic resonance imaging (MRI) and single-photon emission computed tomography (SPECT) could be valuable in the differential diagnosis of...

  • PS May Reverse Early Brain Decline.  // Total Health;Nov2005, Vol. 27 Issue 4, p11 

    The section discusses the role of PhosphatidylSerine in revitalizing the declining brain. Brain decline that noticeably interferes with productivity and personal independence is not a normal feature of aging. A degree of brain decline abnormal for one's age group indicates increased risk for...

  • Towards Omni-Tomography-Grand Fusion of Multiple Modalities for Simultaneous Interior Tomography. Ge Wang; Jie Zhang; Hao Gao; Victor Weir; Hengyong Yu; Wenxiang Cong; Xiaochen Xu; Haiou Shen; Bennett, James; Furth, Mark; Yue Wang; Vannier, Michael // PLoS ONE;Jun2012, Vol. 7 Issue 6, p1 

    We recently elevated interior tomography from its origin in computed tomography (CT) to a general tomographic principle, and proved its validity for other tomographic modalities including SPECT, MRI, and others. Here we propose ''omnitomography'', a novel concept for the grand fusion of multiple...

  • Factors Affecting the Sensitivity and Detection Limits of MRI, CT, and SPECT for Multimodal Diagnostic and Therapeutic Agents. Seevinck, Peter R.; Seppenwoolde, Jan-Henry; de Wit, Tim C.; W. Nijsen, Johannes F.; Beekman, Freek J.; van het Schip, Alfred D.; G. Bakker, Chris J. // Anti-Cancer Agents in Medicinal Chemistry;2007, Vol. 7 Issue 3, p317 

    Noninvasive imaging techniques like magnetic resonance imaging (MRI), computed tomography (CT) and single photon emission computed tomography (SPECT) play an increasingly important role in the diagnostic workup and treatment of cancerous disease. In this context, a distinct trend can be observed...

  • Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability. Roes, Stijntje; Kaandorp, Theodorus; Marsan, Nina Ajmone; Westenberg, Jos; Dibbets-Schneider, Petra; Stokkel, Marcel; Lamb, Hildo; van der Wall, Ernst; de Roos, Albert; Bax, Jeroen // European Journal of Nuclear Medicine & Molecular Imaging;Apr2009, Vol. 36 Issue 4, p594 

    The purpose of this study was to compare contrast-enhanced MRI and nuclear imaging with 99mTc-tetrofosmin and 18F-fluorodeoxyglucose (18F-FDG) single photon emission computed tomography (SPECT) for assessment of myocardial viability. Included in the study were 60 patients with severe ischaemic...

  • Understanding Alzheimer's Disease: The pros and cons of available diagnostic imaging. Nixon, Marie // Synergy: Imaging & Therapy Practice;Jan2014, p27 

    The article discusses the gaps and controversies on existing knowledge about Alzheimer's disease and examines the diagnostic imaging available for its diagnosis. Topics discussed include an overview of the history of the disease, diagnostic methods, common risk factors. Also mentioned are the...

  • The neuroimaging approach to the assessment of mild cognitive impairment. Lucignani, Giovanni // European Journal of Nuclear Medicine & Molecular Imaging;Jun2006, Vol. 33 Issue 6, p745 

    The article presents the imaging techniques in the assessment of mild cognitive impairment (MCI). The single-photon emission computed tomography (SPECT) can be used in patients with amnestic MCI. SPECT scan may predict the conversion of MCI to Alzheimer's disease. Morphometry based on magnetic...

  • Clinical neuroimaging: a matter of biophysics and logistics. Lucignani, Giovanni // European Journal of Nuclear Medicine & Molecular Imaging;Jun2007, Vol. 34 Issue 6, p951 

    The article focuses on the roles of the different imaging techniques in neurological disorders. It was reported that the technological and methodological developments in the area of molecular imaging have led to the widespread use of magnetic resonance imaging and single-photon emission computed...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics